These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10836339)

  • 61. Endothelin A receptor blockade improves regression of flow-induced pulmonary vasculopathy in piglets.
    Mercier O; Sage E; Izziki M; Humbert M; Dartevelle P; Eddahibi S; Fadel E
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):677-83. PubMed ID: 20723731
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
    Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of endothelin-1 and hypoxia-induced pulmonary pressor responses in the rat by a novel selective endothelin-A receptor antagonist, di-n-butylaminocarbamyl-L-leucyl-D-tryptophanyl-D-4-chloro-Phe.
    Yan LD; Kong LL; Yong Z; Dong HJ; Chi MG; Pan XF; Zhang C; Liang YJ; Gong ZH; Liu KL
    J Cardiovasc Pharmacol; 2010 Sep; 56(3):246-54. PubMed ID: 20531217
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080).
    Brunner F; Wölkart G; Haleen S
    J Pharmacol Exp Ther; 2002 Feb; 300(2):442-9. PubMed ID: 11805203
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Endothelin-1 blockade corrects mesenteric hypoperfusion in a porcine low cardiac output model.
    Burgener D; Laesser M; Treggiari-Venzi M; Oi Y; Jolliet P; Strasser S; Hadengue A; Aneman A
    Crit Care Med; 2001 Aug; 29(8):1615-20. PubMed ID: 11505140
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of endothelin ETA receptor antagonism with PD 156707 on hemodynamics and renal vascular resistance in rabbits.
    Ignasiak DP; McClanahan TB; Saganek LJ; Potoczak RE; Hallak H; Gallagher KP
    Eur J Pharmacol; 1997 Mar; 321(3):295-300. PubMed ID: 9085040
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function.
    Pearl JM; Wellmann SA; McNamara JL; Lombardi JP; Wagner CJ; Raake JL; Nelson DP
    Ann Thorac Surg; 1999 Nov; 68(5):1714-21; discussion 1721-2. PubMed ID: 10585047
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension.
    Kim H; Yung GL; Marsh JJ; Konopka RG; Pedersen CA; Chiles PG; Morris TA; Channick RN
    Eur Respir J; 2000 Apr; 15(4):640-8. PubMed ID: 10780753
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets during endotoxic shock.
    Chin A; Radhakrishnan J; Fornell L; John E
    J Pediatr Surg; 2002 Mar; 37(3):482-7. PubMed ID: 11877672
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of N omega-nitro-L-arginine methyl ester on the endotoxin-induced disseminated intravascular coagulation in porcine septic shock.
    Jourdain M; Tournoys A; Leroy X; Mangalaboyi J; Fourrier F; Goudemand J; Gosselin B; Vallet B; Chopin C
    Crit Care Med; 1997 Mar; 25(3):452-9. PubMed ID: 9118662
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Functional estimation of endothelin-1 receptor antagonism by bosentan, macitentan and ambrisentan in human pulmonary and radial arteries in vitro.
    Angus JA; Soeding PF; Hughes RJA; Wright CE
    Eur J Pharmacol; 2017 Jun; 804():111-116. PubMed ID: 28300593
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Splanchnic and systemic hemodynamic responses to portal vein endotoxin after resuscitation from hemorrhagic shock.
    Gavin TJ; Fabian TC; Wilson JD; Trenthem LL; Pritchard FE; Croce MA; Stewart RM; Proctor KG
    Surgery; 1994 Mar; 115(3):310-24. PubMed ID: 8128356
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Age-related differences in responses to endotoxin infusion in unanesthetized piglets.
    Li JX; Oliver JR; Lu CY; Grantham KD; Philips JB
    Circ Shock; 1993 Sep; 41(1):40-7. PubMed ID: 8403245
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
    Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
    Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Discovery and development of an endothelin A receptor-selective antagonist PD 156707.
    Doherty AM; Uprichard AC
    Pharm Biotechnol; 1998; 11():81-112. PubMed ID: 9760677
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of endothelin receptor activation in secondary pulmonary hypertension in awake swine after myocardial infarction.
    Houweling B; Merkus D; Sorop O; Boomsma F; Duncker DJ
    J Physiol; 2006 Jul; 574(Pt 2):615-26. PubMed ID: 16709643
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo.
    Holm P; Liska J; Franco-Cereceda A
    Cardiovasc Res; 1998 Mar; 37(3):765-71. PubMed ID: 9659461
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of platelet-activating factor antagonism in posthemorrhage septic shock in pigs.
    Abu-Zidan FM; Walther S; Lennquist S
    J Trauma; 1996 Oct; 41(4):634-40. PubMed ID: 8858021
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The endothelin antagonist bosentan: hemodynamic effects during normoxia and hypoxic pulmonary hypertension in pigs.
    Holm P; Liska J; Clozel M; Franco-Cereceda A
    J Thorac Cardiovasc Surg; 1996 Oct; 112(4):890-7. PubMed ID: 8873714
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Atrasentan treatment of pulmonary vascular disease in piglets with increased pulmonary blood flow.
    Gorenflo M; Ullmann MV; Herpel E; Neumayer S; Dieckmann R; Demirakca S; Klimpel H; Hagl S; Gebhard MM
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):286-92. PubMed ID: 17878757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.